Co-development agreements involve both companies working together to develop a specific product or technology.

Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

Current vice president and Democratic Party presidential nominee Kamala Harris has proposed sweeping changes designed to ...

After Wegovy and Ozempic by pharmaceutical company Novo Nordisk, Netherlands residents will soon also have access to another ...

America’s Eli Lilly is locked in a fight with Denmark’s Novo Nordisk to control the weight loss market. One product could ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

A group representing companies that made copycat versions of Eli Lilly & Co.’s weight-loss drugs sued the US Food and Drug ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

Novo Nordisk (NVO) and Viatris (VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo ...

Christine Zhou started her career as a physician and clocked nearly two decades at drugmaker Eli Lilly before joining rival Novo Nordisk in 2018, where she is now president for the China region. China ...

Novo Nordisk and Mylan Pharmaceuticals, now part of Viatris, have settled their patent dispute over Novo’s blockbuster ...